Skip to main content


Health

During a phase one clinical trial of a new treatment for MS patients, researchers were able to curtail the body's attacks on myelin by 50 to 75 percent, while sustaining the functionality of the rest of the immune system.
335 of 1543




Newsletter Sign Up

Daily Readings

Reading 1, First Corinthians 2:1-5
Now when I came to you, brothers, I did not come with any ... Read More

Psalm, Psalms 119:97, 98, 99, 100, 101, 102
How I love your Law! I ponder it all day long. You make me ... Read More

Gospel, Luke 4:16-30
He came to Nazara, where he had been brought up, and went into ... Read More

Saint of the Day

September 1 Saint of the Day

St. Giles, Abbot
September 1: St. Giles, Abbot (Patron of Physically Disabled) Feast day - ... Read More